Library / learning-module
Understanding cell and gene therapies
Audience: patients-public, students-learners ยท Review state: published
Treating disease at its root
Cell and gene therapies aim to treat disease by modifying the body's own biological machinery rather than by managing symptoms. Regulators define gene therapy as products that mediate their effect by transcription or translation of transferred genetic material, or by specifically altering human genetic sequences.
Cell therapy transfers whole living cells into a patient; gene therapy delivers or edits genetic material inside the patient's cells. Some products combine both: cells are removed, genetically modified in a laboratory, and returned.
How gene delivery works
Most gene therapies use a vector, often a harmless, disabled virus, to carry the therapeutic gene into target cells. Others use non-viral delivery or direct gene editing, where molecular tools correct a faulty sequence in place.
The therapeutic gene may replace a missing function, switch off a harmful one, or give cells a new ability, such as training immune cells to recognize cancer.
Where these therapies already stand
Approved cell and gene therapies treat certain blood cancers, inherited retinal disease, spinal muscular atrophy and other rare conditions. Regulatory agencies maintain lists of approved products, and the pipeline in clinical trials extends to blood disorders, metabolic disease and more.
These are prescription-only, single-specialty-center treatments, not general-practice medicines. Many are one-time treatments intended to produce lasting benefit.
Realistic expectations
Cell and gene therapies can produce dramatic, durable responses, but they are not universal cures. Effects vary between patients, some benefits take time, and long-term follow-up, often 15 years for gene therapies, is required because late effects may emerge slowly.
Risks include immune reactions to the vector or cells and unintended effects of genetic change. Cost and access remain significant barriers worldwide, and any offer of gene therapy outside an approved product or a registered trial should be treated with extreme caution.
Limitations
Educational overview of cell and gene therapy, not a guide to any specific treatment. Eligibility decisions belong with specialist centers.